CABALETTA BIO INC
CABALETTA BIO INC logo
CABA

CABALETTA BIO INC (CABA)

$4.970.61%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.89
Day's Range
$5.32
$0.59
52-Week Range
$13.24
1 month return127.98%
3 month return402.32%
1 year return53.46%
5 year return50.3%

Company Information

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. The Cabaletta Approach to selective B cell Ablation (CABA) platform, in combination with Cabaletta's proprietary technology, utilizes Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to selectively bind and eliminate only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. The Company's lead product candidate, DSG3-CAART, is being evaluated in the DesCAARTes™ phase 1 clinical trial as a potential treatment for patients with mucosal pemphigus vulgaris, a prototypical B cell-mediated autoimmune disease. The FDA granted Fast Track Designation for DSG3-CAART in May 2020. The Company's lead preclinical product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated myasthenia gravis.
OrganizationCABALETTA BIO INC
Employees57
CEODr. Steven A. Nichtberger M.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for CABALETTA BIO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 57.55%

Current

$4.97

Target

$7.83

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
11
11
Hold
0
2
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
143.3M
Book Value
$2.96
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.83
Wall Street Target Price
7.83

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.31
Enterprise Value
57.4M
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-1.13

Technicals

Beta
2.55
50 Day MA
2.02
200 Day MA
1.62

Institutional Holdings

Adage Capital Partners Gp LLC

8.76%

Vanguard Group Inc

4.41%

Citadel Advisors Llc

4.32%

Cormorant Asset Management, LLC

3.98%

Redmile Group, LLC

2.4%

Baker Bros Advisors LP

2.28%

Discover more

Frequently Asked Questions

What is CABALETTA BIO INC share price today?

Can Indians buy CABALETTA BIO INC shares?

How can I buy CABALETTA BIO INC shares from India?

Can Fractional shares of CABALETTA BIO INC be purchased?

What are the documents required to start investing in CABALETTA BIO INC stocks?

What are today’s High and Low prices of CABALETTA BIO INC?

What are today’s traded volumes of CABALETTA BIO INC?

What is today’s market capitalisation of CABALETTA BIO INC?

What is the 52 Week High and Low Range of CABALETTA BIO INC?

How much percentage CABALETTA BIO INC is down from its 52 Week High?

How much percentage CABALETTA BIO INC is up from its 52 Week low?

What are the historical returns of CABALETTA BIO INC?

Who is the Chief Executive Officer (CEO) of CABALETTA BIO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*